Henrik Zetterberg (neurochemist)

Henrik Zetterberg (born 1973)[2] is a Swedish professor of neurochemistry at the University of Gothenburg, where he is the Head of the Department of Neurochemical Pathophysiology and Diagnostics.[3] He is also the leader of the Fluid biomarkers for neurodegenerative diseases group at University College London. The groups work on developing early tests for dementia.[4]

Henrik Zetterberg
Born1973 (age 50–51)
Alma materUniversity of Gothenburg
Known forAlzheimer research
Scientific career
FieldsNeurochemistry
InstitutionsUniversity of Gothenburg and University College London
Doctoral advisorLars Rymo[1]
Other academic advisorsDennis J. Selkoe

Early life and career edit

Zetterberg was born[2] and brought up in the Gothenburg archipelago, Sweden.[1] He completed his doctoral thesis in 2003 on the subject of the Epstein–Barr virus.[5] He performed postdoctoral research at Harvard using zebrafish as a model for alzheimer's disease.[6][1] Zetterberg has worked together with Kaj Blennow, whom he met during his PhD, on many projects including coleading the Clinical Neurochemistry Laboratory together with him.[1]

Research edit

His research includes the development of methods for early diagnostics for frontotemporal dementia through the use of Biomarkers,[7] In 2020, a team of scientists led by Zetterberg published results regarding a new diagnostic for Alzheimer's disease based on protein concentrations in cerebrospinal fluid, which is a colorless fluid surrounding the brain and spinal cord. The test was reported to have an accuracy of around 90% and could detect the disease about two decades before significant symptoms were present.[8]

References edit

  1. ^ a b c d Kirby, Tony. "Henrik Zetterberg: biomarking neurological" (PDF). thelancet.com. The Lancet. Retrieved 7 May 2021.
  2. ^ a b "Henrik Zetterberg - Sveriges Unga Akademi". www.sverigesungaakademi.se. Sveriges Unga Akademi. Retrieved 6 May 2021.
  3. ^ "Henrik Zetterberg | Göteborgs universitet". www.gu.se (in Swedish). University of Gothenburg. Retrieved 6 May 2021.
  4. ^ Institute, UK DRI: UK Dementia Research (6 May 2021). "Meet the team: Henrik Zetterberg". ukdri.ac.uk. UK Dementia Research Institute. Retrieved 7 May 2021.
  5. ^ Zetterberg, Henrik (2003). Transcriptional regulation of the Epstein-Barr virus nuclear antigen 1 gene in latent and lytic stages of infection. ISBN 91-628-5749-5.
  6. ^ Lundgren, Eva (2013-06-17). "Profilen: Henrik Zetterberg – Med nyfiket sinne". GU Journalen. No. 4 2013. University of Gothenburg.
  7. ^ "Han för demensforskningen framåt på flera sätt". www.hjarnfonden.se (in Swedish). Hjärnfonden. 19 September 2018. Retrieved 6 May 2021.
  8. ^ Fredholm, Lotta (9 December 2020). "Nytt slags blodtest hittar alzheimer tidigt". fof.se (in Swedish). Forskning & Framsteg. Retrieved 6 May 2021.